Market capitalization | $2.08b |
Enterprise Value | $2.01b |
P/E (TTM) P/E ratio | 32.51 |
EV/FCF (TTM) EV/FCF | 28.77 |
EV/Sales (TTM) EV/Sales | 1.17 |
P/S ratio (TTM) P/S ratio | 1.21 |
P/B ratio (TTM) P/B ratio | 2.88 |
Revenue growth (TTM) Revenue growth | 29.71% |
Revenue (TTM) Revenue | $1.72b |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
11 Analysts have issued a Astrana Health forecast:
11 Analysts have issued a Astrana Health forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,722 1,722 |
30%
30%
|
|
Gross Profit | 235 235 |
18%
18%
|
|
EBITDA | 109 109 |
7%
7%
|
EBIT (Operating Income) EBIT | 85 85 |
16%
16%
|
Net Profit | 62 62 |
36%
36%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam on November 1, 1985 and is headquartered in Alhambra, CA.
Head office | United States |
CEO | Brandon Sim |
Employees | 1,800 |
Founded | 1985 |
Website | www.astranahealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.